insights_auto
Why is KROS down 2.82%?
Dive Deeperchevron_right
KROS:NASDAQ
Keros Therapeutics Inc
$11.04
arrow_downward
-2.82%(-0.32) 1D
Oct 30, 3:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KROS...
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
0.00
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
0.00
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
News stories
From web sources and news partners
TradingView
·
1 hour ago
IXIC: Nasdaq Futures Rebound with Apple Earnings, US Midterm Elections Ahead
The Dark Side Of The Boom
·
46 minutes ago
Wall Street's AI Unwind: Goldman Finds Seven Signs the Selling May Be Running Out of Road
Benzinga
·
1 hour ago
S&P 500 Is Up '19 For 19 Times' In Midterm November-April Window, According To Ryan Detrick
The Motley Fool
·
5 hours ago
The S&P 500's Shiller P/E Is Above 40. History Says What Happened the Only Other Time.
About Keros Therapeutics Inc
CEO-
Employees92
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitekerostx.com